Background
==========

The World Health Organization (WHO) encourages all countries to monitor the magnitude and causes of visual impairment in order to scrutinize and eliminate avoidable blindness \[[@B1]\]. Registered data can provide valuable information regarding blindness. Blindness registries mainly exist in developed countries and are held by state or partially state funded organizations that provide some kind of assistance to the visually disabled\[[@B2]\]. China is a developing country and cannot provide funds to establish a nationwide networked blindness registry. Also varied socioeconomic conditions affect the development of this project in different regions of China.

Shanghai is the largest metropolis in China and its GDP per capita reached \$10,529 USD in 2008\[[@B3]\]. Jing-An district is among the nine downtown districts of Shanghai, where a public welfare system is most developed. Jing-An district established a blindness registry in 1992, which is held by the local Disabled Person\'s Federation (DPF), which is funded by the local government. Although registration is entirely voluntary, it confers significant practical and monetary benefits. We analyzed the data from the Jing-An district DPF with specific objectives including: (1) to identify the causes of registered blindness and to calculate the gender and age-specific prevalence of blindness; (2) to calculate the 3-year incidence of registered blindness in the most recent 9 years; and (3) to suggest priorities for research and intervention strategies for blindness.

Methods
=======

This study is based on the blindness data of the Jing-An district DPF. Age, gender and cause of visual disability data were collected and analyzed. The prevalence at the end of years 2003, 2007, 2009 and the 3-year incidence of blindness was calculated. The study was performed in accordance with the Declaration of Helsinki for research involving human subjects. The study met all standards for ethical approval in China, and the protocol was approved by the institutional board at the health bureau of Shanghai, China.

The criteria for registering blindness in China are in accordance with the WHO categories of visual impairment, and the category of interest for our study was that the visual impairment was irreversible \[[@B4]\]. Blindness was defined as a best spectacle corrected visual acuity (BSCVA) of less than 3/60 in the better eye, or a corresponding visual field loss to less than 10 degrees in the better eye with best possible correction.

All registered blindness cases need to undergo an assessment of visual impairment. The assessment system has been in place in Jing-An district central hospital from 1992 to the present. In the first 9 years, the causes of blindness were not recorded. From 2001, a comprehensive ocular examination was performed on every applicant including uncorrected visual acuity (UCVA), refraction, BSCVA, ophthalmoscope examination and retinal photography. Visual field tests were performed by a kinetic arctic perimeter (YZ22, 66 Vision Tech. Co., Ltd, China) when visual disability was due to glaucoma, retinitis pigmentosa (RP) and other optic nerve diseases.

The causes of blindness were classified according to the International Classification of Diseases, 10th edition \[[@B5]\]. Myopic macular degeneration (MMD) was considered only in subjects with a refractive error exceeding -6.0 diopters in either eye with one or more of the following ophthalmologic findings: tessellated fundus with yellowish white diffuse or grayish white patchy chorioretinal atrophy, macular hemorrhage or posterior staphyloma \[[@B6]\]. Age-related macular degeneration (AMD) was defined according to the Wisconsin age-related maculopathy grading system \[[@B7]\]. Early AMD was defined by the presence of either soft indistinct drusen or the presence of any type of drusen associated with retinal pigment epithelium depigmentation or increased retinal pigment. Late AMD was defined by the appearance of either exudative macular degeneration or pure geographic atrophy. Glaucoma was defined according to the International Society for Geographical and Epidemiological Ophthalmology classification \[[@B8]\]. Diagnosis of RP was based on night blindness, progressive loss of peripheral visual field, and decreased visual acuity with age, as well as on typical signs observed under fundus examination. The diagnosis of diabetic retinopathy, corneal opacity, and other diseases as causes of blindness followed the ophthalmology practice guidelines edited by the China Academy of Ophthalmology.

Using best judgement, the ophthalmologist attempted to identify the disorder causing the greatest limitation of vision as the cause of blindness. The causes of blindness in both eyes were recorded. When two causes appeared to have an equal contribution to visual impairment for one eye, the primary cause was assigned as the cause of blindness. If cataract was regarded as the main cause of blindness, the patient was referred for surgery and reassessed at least 2 months postoperatively if visual function restored unsatisfactorily.

Statistical analysis was performed using SPSS software version 13 (SPSS, Inc., Chicago, IL). The incidence of blindness caused by some diseases is low and varied in different years in a defined area, so we calculated the 3-year incidence of registered blindness per 100,000 in order to reduce the deviation of incidence in different year. And the prevalence of registered blindness per 100,000 were also calculated. Age was grouped as 1 y - 29 y, 30 y - 49 y, 50 y - 69 y and 70 y or older. Binary logistic regression was used to analyze the factors related to the occurrence of registered blindness. Odds ratios and 95% confidence intervals were determined to describe the influence of age and gender on the prevalence of visual impairment. A Chi-square test was used to analyze the difference between genders. P \< 0.05 was considered as statistically significant.

Results
=======

Prevalence and causes
---------------------

The number of people in the blindness registry increased from 378 in 2003 to 458 in 2006 to 514 in 2009. The reported blindness also increased significantly from 114.7 per 100, 000 in 2003 to 145.8 per 100,000 in 2006 to 165.9 per 100,000 in 2009 (P \< 0.05, P \< 0.05, respectively). The age-specific prevalence and gender-specific prevalence for 2009 are summarized in Table [1](#T1){ref-type="table"}. The association of sex and age with blindness was calculated with a logistic regression model, as shown in Table [2](#T2){ref-type="table"}. Gender was not a significant factor, but age significantly affected the prevalence. The odd ratios (OR) were 2.57 in the 30 y - 49 y group (P \< 0.001), 7.27 in the 50 y - 69 y group (P \< 0.001), and 21.2 in the 70 y or older group (P \< 0.001).

###### 

Prevalence of blindness in Jing-An district, Shanghai, China in 2009

           Age(yrs)    population   blind   Prevalence   95%CI   
  -------- ----------- ------------ ------- ------------ ------- -------
  FEMALE                                                         
           1-29        43152        15      34.8         17.2    52.3
           30-49       42425        22      51.9         30.2    73.5
           50-69       47173        109     231.1        187.7   274.4
           70 or 70+   25822        112     433.7        353.6   513.9
           Total       158572       258     162.7        142.9   182.5
  MALE                                                           
           1-29        44153        7       15.9         4.1     27.6
           30-49       40752        39      95.7         65.7    125.7
           50-69       47383        87      183.6        145.1   222.2
           70 or 70+   18893        123     651          536.3   765.7
           Total       151181       256     169.3        148.6   190.1
  TT                                                             
           1-29        87305        22      25.2         14.7    35.7
           30-49       83177        61      73.3         54.9    91.7
           50-69       94556        196     207.3        178.3   236.3
           70 or 70+   44715        235     525.6        458.5   592.6
           Total       309753       514     165.9        151.6   180.3

###### 

Association of registered blindness with gender and age in Jing-an district in 2009

                    OR      95%CI   P       
  ----- ----------- ------- ------- ------- ---------
  Sex   male        1                       
        female      0.87    0.73    1.04    0.12
  age   1-29        1                       
        30-49       2.57    2.13    3.11    \<0.001
        50-69       7.27    5.48    9.63    \<0.001
        70 or 70+   21.20   13.69   32.84   \<0.001

CI: confidence interval

OR: odds ratio (binary logistic regression)

The leading causes of blindness that were registered in 2001-2009 are summarized in Table [3](#T3){ref-type="table"}. The causes of blindness were MMD (19.4%), followed by glaucoma (17.7%), AMD (11.8%), optical nerve atrophy (9.4%), RP (8.6%), diabetic retinopathy (7.8%) and corneal opacity (5.8%).

###### 

Causes of new registered blindness in Jing-An district, Shanghai, China in 2001-2009

             2001-2003   2004-2006   2007-2009                                                                                           
  ---------- ----------- ----------- ----------- --- ----------------- ----- ----- ------- --- ----------------- ----- ----- ------- --- -----------------
  MMD        15          29          14.5        2   4.8(2.4,7.3)      17    32    15.1    1   5.5(2.9,8.1)      39    74    26.1    1   12.6(8.6,16.5)
  Glaucoma   19          38          19.0        1   6.1(3.4,8.9)      16    32    15.1    1   5.2(2.6,7.7)      28    53    18.7    2   9.0(5.7,12.4)
  AMD        13          20          10.0        5   4.2(1.9,6.5)      16    29    13.7    3   5.2(2.6,7.7)      19    33    11.6    3   6.1(3.4,8.9)
  RP         6           11          5.5         7   1.9(0.4,3.5)      13    26    12.3    4   4.2(1.9,6.5)      12    23    8.1     4   3.9(1.7,6.1)
  Diabetic   8           16          8.0         6   2.6(0.8,4.4)      8     16    7.6     6   2.6(0.8,4.4)      11    22    7.8     5   3.6(1.5,5.6)
  CO         3           4           2.0         9   1.0(0,2.1)        10    15    7.1     7   3.2(1.2,5.2)      16    21    7.4     6   5.2(2.6,7.7)
  RD         15          27          13.5        3   4.8(2.4,7.3)      5     8     3.8     8   1.6(0.2,3.0)      10    16    5.6     7   3.2(1.2,5.2)
  ONA        13          26          13.0        4   4.2(1.9,6.6)      14    25    11.8    5   4.5(2.2,6.9)      7     14    4.9     8   2.3(0.6,3.9)
  UVITIS     3           6           3.0         8   1.0(0,2.1)        4     7     3.3     9   1.3(0,2.6)        6     10    3.5     9   1.9(0.4,3.5)
  OTHERS     17          23          11.5            5.5(2.9.8.1)      12    22    10.4        3.9(1.7,6.1)      16    18    6.3         5.2(2.6,7.7)
  Total      100         200         100.0           32.3(25.9,38.6)   106   212   100.0       34.2(27.7,40.7)   142   284   100.0       45.8(38.3,53.4)

MMD: myopic macular degeneration; AMD: age-related macular degeneration; ONA: optic nerve atrophy; RP: retinitis pigmentosa; CO: corneal opacity; RD: retinal detachment.

3-year incidence
----------------

The 3-year incidence of registered blindness increased from 32.3 (range 26.0-38.6) per 100,000 in 2001-2003 to 34.2 (range 20.7-40.7) per 100,000 in 2004-2006 to 40.8 (range 40.1-55.5) per 100,000 in 2007-2009 (Table [4](#T4){ref-type="table"}). In the blindness registry, retinal detachment was the third cause in 2001-2003, but became the eighth in 2004-2006 and the seventh cause in 2007-2009. Optic nerve atrophy was the fourth cause of blindness in 2001-2003, and became the seventh cause in 2004-2006 and the eighth cause in 2007-2009. However, AMD was the fifth cause in 2001-2003, the third in 2004-2006, and the third in 2007-2009.

###### 

Prevalence and 3-years-incidences of blindness in Jing-An district, Shanghai, China.

                                          2001-2003            2004-2006            2007-2009
  --------------------------------------- -------------------- -------------------- --------------------
  Population(10,000)                      33.24                30.96                30.97
  Blind                                   378                  458                  514
  Prevalence rate (95%CI)(1/100,1000)     113.7(102.3-125.2)   147.9(134.4-161.5)   165.9(151.6-180.3)
  New blind                               100                  106                  142
  3-year-incidence (95%CI) (1/100,1000)   32.3(26.0-38.6)      34.22(27.7-40.7)     47.78(40.1-55.5)

Age and new blindness
---------------------

The ages of the registered cases of new blindness is summarized in Table [5](#T5){ref-type="table"}. The average registered age was 64.19 ± 15.86 y. The average registered age increased from 60.1 ± 17.3 y in 2001-2003 to 65.4 ± 15.2 y in 2004-2006 to 66.1 ± 14.8 y in 2007-2009 (P \< 0.05, P \< 0.05, respectively). The main reason for the increased age of new blindness was that there was an increase in the age of the registered blind due to MMD, optic nerve atrophy, corneal opacity and AMD.

###### 

Registered age of new blindness in Jing-An district, Shanghai, China.

             2001-2009       2001-2003       2004-2006         2007-2009
  ---------- --------------- --------------- ----------------- -----------------
  Glaucoma   67.30 ± 14.61   65.89 ± 14.01   67.94 ± 16.23     67.89 ± 14.52
  Diabetic   63.00 ± 13.79   63.38 ± 13.73   58.00 ± 14.14     63.64 ± 14.92
  MMD        61.32 ± 12.22   54.60 ± 16.61   61.12 ± 11.36     64.00 ± 9.68\*
  RP         57.29 ± 13.83   58.00 ± 13.28   59.15 ± 10.16     54.92 ± 17.83
  AMD        75.31 ± 9.42    71.00 ± 8.98    77.70 ± 9.28\*    75.74 ± 9.31
  ONA        59.25 ± 17.43   53.23 ± 19.74   66.69 ± 12.24\*   53.43 ± 18.82
  CO         67.52 ± 16.55   43.00 ± 33.87   66.40 ± 11.50\*   72.81 ± 11.33\*
  RD         61.97 ± 13.78   57.47 ± 15.58   68.80 ± 8.81      65.30 ± 11.28
  UVITIS     62.77 ± 14.93   60.33 ± 14.15   59.25 ± 11.95     66.33 ± 18.45
  OTHERS     59.93 ± 23.18   58.44 ± 21.51   54.18 ± 27.03     65.73 ± 22.16
  Total      64.19 ± 15.86   60.10 ± 17.29   65.43 ± 15.24\*   66.12 ± 14.82\*

MMD: myopic macular degeneration; AMD: age-related macular degeneration ONA: optic nerve atrophy; RP: retinitis pigmentosa; CO: corneal opacity; RD: retinal detachment.

\*:P \< 0.05 compared to in 2001-2003

Discussion
==========

To our knowledge, this is the first report on registered blindness in China. Because of the varied socioeconomic levels in China, and the independence of registries in different regions, it is impossible to obtain a complete national dataset, as well as a complete dataset for Shanghai. We therefore analyzed limited data based on the blindness registry in Jing-An district, Shanghai, China.

The number of people in the blindness registry in Jing-An district has increased by 36% since 2003 and by 13% since 2007. In contrast, the population of the district remained stable. The increase in the prevalence and incidence of blindness during 2001-2009 likely represents increased registration rather than increasing levels of disease, considering the short time period involved. Higher life expectancy in the general population in Shanghai may have contributed as well; according to an official publication of the Shanghai Bureau of Statistics, life expectancy in 2001 was 79.7 y and 81.3 y in 2009\[[@B3]\].

Currently, the overall prevalence of blindness is 0.17% for the total population, 0.21% for ages 50 y - 69 y, and 0.53% for ages 70 y or older. The prevalence in this study is lower than that reported in most studies based on a sample of the population in urban China (Table [6](#T6){ref-type="table"}) \[[@B6],[@B9]-[@B19]\]. This is possibly due to inclusion of blindness due to cataracts in the studies. A recent study showed the prevalence of blindness was 0.61% for ages 70 y or older in Shanghai and 29.4% was due to cataract \[[@B17]\], which is a prevalence rate closer to our results. Another study in Henan province showed that the prevalence of blindness in urban areas was only 0.09% \[[@B18]\]. To our knowledge, there are no data available on the incidence of blindness in China to compare with this study. It is difficult to compare the incidence and prevalence of blindness with other countries because of different definitions of blindness and difference age distributions. The prevalence of registered blindness was 0.17% - 0.22% in Ireland (blindness was defined as BSCVA in the better eye of less than 6/60)^2^and 0.26% - 0.32% in Israel (using WHO criteria) \[[@B20]\]. The incidence of registered blindness was 0.036% - 0.029% in Israel (using WHO criteria), 0.02% in Ireland (using US criteria) and 0.012% in southern Germany (blindness was defined as BSCVA in the better eye of less than 1/50) \[[@B20]-[@B22]\]. In our study, blindness was defined by WHO criteria and cataract was extirpated as the cause of registered blindness. Young babies were also enrolled in this study, which would decrease the prevalence and incidence of blindness.

###### 

Prevalence of blindness and its causes reported from population based studies in china

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country                    Age(yrs)   Prevalence           Main causes
  -------------------------- ---------- -------------------- -------------------------------------------------------------------------------------------------------------------------------
  Beijing, China\            \> = 40    0.3%                 Cataract(38.5%); Cornea opacity (15.4%);Myopic macular degeneration(7.7%); Glaucoma(7.7%)
  (Xu L et al.2006)                                          

  Handan china\              \> = 30    0.5%                 Cataract (36.6%);Myopic macular degeneration (19.5%)\
  (Liang YB et al. 2008)                                     Glaucoma(7.3%);Cornea opacity(7.3%)

  Taiwan, China\             \> = 65    0.59%                Cataract (41.7%);Myopic macular degeneration (12.5%)\
  (Hsu WM, et al. 2004)                                      AMD(10.4%)

  Hongkong, China\           \> = 60    1.8%                 Cataract (51.7%);Macular degeneration (27.1%)\
  (Michon JJ, et al. 2002)                                   Glaucoma(7.1%)

  Hebei, China\                         0.19%\               Cataract(32.3%);trachoma complications(13.4%)\
  (Song XJ.1992)                        in urban areas       corneal disease(13.06%);glaucoma(9.97%)

  Shanxi, China\                        0.18%\               Cataract (29.7%)
  (Zhang JX.1990)                       in cities            

  Shangdong, china\                     0.34%                Cataract, corneal diseases and glaucoma in urban areas
  (Yu XM.1992)                                               

  China\                                0.43%                Cataract(41.06%);Corneal disease(15,38%)\
  (Zhang SY.1992)                                            Trachoma (10.4%);Glaucoma (8.8%)

  Chongqing, china\          \>50       1.8%                 Cataract (17.9%);Retinal diseases (20.7%); refraction error(15.4%);\
  (Liu S, et al. 2007)                                       cornea disease (11.6%); glaucoma (13.4%)

  Shanghai\                             0.95%\               Macular degeneration(28.57%);Cataract(27.27%); Corneal opacity (6.49%);\
  (Huang XB, et al. 2009)               in 60-79 yrs\        Retinal detachment (5.84%); Optical nerve atrophy (5.19%); Retinitis pigmentosa (5.19%)
                                        0.68%\               
                                        in 70-79 yrs\        
                                        0.40%yrs\            
                                        in 80 yrs or older   

  Henan\                                0.09%\               no noted
  (Li Y et al.2009)                     in urban             

  Hubei\                                0.33%\               Cataract (54.55%);Glaucoma(10.22%); Congenital abnormal (8.41%);Corneal disease(7.48%); Retinal and choroidal disease (6.54%)
  (Chen W et al. 2009)                  in urban             
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The leading causes of blindness in the present study were MMD (22.6%), glaucoma (18.7%), AMD (11.6%) and RP (8.1%). Some studies showed that corneal opacity was also a major cause of blindness in China (shown in Table [5](#T5){ref-type="table"}) \[[@B9],[@B12]-[@B18]\]. In the present study corneal opacity was the eighth cause of blindness. Although the number of cases of corneal opacity increased, along with an increase in the registered age from 43.0 ± 33.9 y in 2001-2003 to 72.8 ± 11.3 y in 2007-2009, visual acuity must have been lost in an earlier stage. The reason for this is that infectious keratitis and trachoma have been well controlled in Shanghai. A recent study showed that glaucoma was the eighth cause of blindness and accounted for 4.1% of blindness in Shanghai, whereas it was the second cause at 18.7% in the present study \[[@B17]\]. However, no visual field examinations were performed in their study. AMD has increased dramatically as a cause of blindness. It was the fifth cause in 2001-2003, while it became the third cause in 2007-2008. The pattern of causes of blindness was similar to that in Taiwan, Hongkong, and Western countries \[[@B6],[@B11],[@B20]-[@B22]\]. Glaucoma and AMD have also become the leading causes of blindness in the Jing-An district of Shanghai.

The analysis shows the importance of glaucoma as the leading cause of blindness in China today. Most patients with glaucoma can maintain sufficient visual acuity if effective treatment is given at an early stage, especially for primary angle-closure glaucoma (PACG), which is major category of glaucoma in China. The study showed that 92.86% of blindness due to glaucoma occurred at 51 y or older. We therefore suggest that local health bureaus should conduct glaucoma screening for those aged 51 y or older to diagnose glaucoma at an early stage.

AMD and MMD are the chief causes leading to blindness. Unfortunately, for most people with AMD, vision loss can neither be prevented nor adequately reversed. There is clearly a need for further research on the causes and risk factors of AMD. Persons with MMD will also benefit from the research. Controlling the development of high myopia is impending. Research on the mechanisms of myopia progression is necessary to decrease the vision impairment burden of students.

This study is based on registered data for a defined geographic area. We acknowledge there are some limitations in our study. We had to rely on the limited information from the CDPF, and the causes of blindness registered before 2001 were not recorded. The increase in the prevalence and incidence of blindness likely represents increased registration rather than increasing levels of disease. In this study, the cause of blindness was recorded for each eye, which would increase the proportion of disorders with a bilateral tendency such as AMD, MMD and glaucoma as the cause of blindness. It would be better to record the causes by case. The efficacy of the registration system is not certain. Previous studies in other countries found that only 45% - 60% of eligible patients were registered \[[@B23]\]. It is therefore necessary to make a dedicated effort to evaluate the efficacy of the registry system in China.

Conclusions
===========

The 3-year incidence and reported blind increased in the past 9 years. The leading causes of new cases of blindness that were registered were MMD, glaucoma and AMD. The pattern of causes has changed little in the past 9 years, is different from other locations in China, and is similar to patterns in Taiwan, Hongkong and Western countries.
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